About SPRING MILL PHARMA INCORPORATED
Spring Mill Pharma, Inc. is a Pennsylvania-based company formed in 2025 by Dr. Daniel Pevear following the discontinuation of Venatorx Pharmaceuticals' discovery research. The company focuses on developing innovative medicines for serious infectious diseases with limited treatment options.
Research and development of innovative medicines for serious infectious diseasesDevelopment of novel therapies to combat resistant bacterial infections and emerging viral pathogens
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to SPRING MILL PHARMA INCORPORATED right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.